Oligodendroglioma - 26 Studies Found

Completed : Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma
: Glioma : Oligodendroglioma or Astrocytoma
: 2013-10-10
: Device: Molecular and cellular tumor print Medical Device (ProTool) Proteomic, genomic and cellular cult
Completed : Prolonged Daily Temozolomide for Low-Grade Glioma
:
  • Glioma
  • Astrocytoma
  • Oligodendroglioma
    : 2005-09-09
    : Drug: Temozolomide Given once daily for 49 days followed by 28 days with no drug for a maximum of a year
Completed : First in Patient Study for PF-06840003 in Malignant Gliomas
:
  • Oligodendroglioma
  • Astrocytoma
  • : 2016-04-27
    : Drug: PF-06840003 Daily Oral PF-06840003
Active, not recruiting : Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
:
  • Adult Anaplastic Oligodendroglioma
  • Adult Giant Cell Glioblastom
    : 2012-05-30
    :
    • Drug: Bevacizumab 10 mg/kg on

Terminated : RO4929097 in Treating Patients With Recurrent Invasive Gliomas
:
  • Adult Anaplastic Oligodendroglioma
  • Adult Brain Stem Glioma

    • : 2010-12-31
    :
    • Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097

Recruiting : Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
:
  • Childhood Astrocytoma
  • Childhood Atypical Teratoid/Rhabdoid Tumor
  • Other: Laboratory Biomarker Analysis

<<< Previous